SANCTURA XR
LOE ApproachingNDAORALCAPSULE, EXTENDED RELEASE
Approved
Aug 2007
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
1
Data completeness
2/8 — Basic
Drug data last refreshed 8h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
SANCTURA XR is an extended-release oral capsule small-molecule antispasmodic approved in 2007 by AbbVie. The drug treats overactive bladder and related urinary conditions through anticholinergic mechanism. Patient population includes adults with urge incontinence, urgency, and urinary frequency.
LOE Approaching
Product is approaching loss of exclusivity with moderate competitive pressure (30/100), signaling potential team downsizing or reallocation within AbbVie.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (1)
Efficacy of Sanctura XR (Trospium Chloride) for Reducing Overactive Bladder Symptoms in Female Subjects Refractory to Detrol LA (Tolterodine Tartrate Extended Release) Daily
Started Mar 2010
322 enrolled
Overactive Bladder
Career Relevance
Working on SANCTURA XR offers limited long-term growth potential given LOE-approaching status and zero linked job openings. Career value centers on defensive brand management, generic transition planning, and portfolio optimization experience rather than expansion opportunity.
Brand Manager
Worked on SANCTURA XR at AbbVie? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.